Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
China flag China · Delayed Price · Currency is CNY
14.67
-0.11 (-0.74%)
Feb 13, 2026, 3:00 PM CST

SHA:600535 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
955.591,071-264.242,359
Depreciation & Amortization
484.02504.91517.95487.77
Other Amortization
18.4811.2314.7315.23
Loss (Gain) From Sale of Assets
-2.11-0.15-1.48-44.22
Asset Writedown & Restructuring Costs
218.011.78352.26265.48
Loss (Gain) From Sale of Investments
198.5270.751,158-1,682
Provision & Write-off of Bad Debts
0.628.19-1.34-5.35
Other Operating Activities
-73.79-2.03-31.24123.82
Change in Accounts Receivable
78.221,243535.511,231
Change in Inventory
18.32-220.72-2.86-198.37
Change in Accounts Payable
121.58-395.3536.56243.78
Change in Other Net Operating Assets
-67.7611.013.44
Operating Cash Flow
2,0152,5762,2802,801
Operating Cash Flow Growth
-21.78%12.98%-18.62%56.39%
Capital Expenditures
-564.94-668.82-404.41-571.73
Sale of Property, Plant & Equipment
27.581.191.3468.92
Cash Acquisitions
----147.31
Divestitures
---424.19
Investment in Securities
-287.57-134.14-919.91126.42
Other Investing Activities
-115.99-1,30756.7556.76
Investing Cash Flow
-940.87-2,109-1,266-42.83
Short-Term Debt Issued
1,052213.91102.791
Long-Term Debt Issued
1,4511,8172,7111,441
Total Debt Issued
2,5042,0312,8141,442
Short-Term Debt Repaid
-1,132-127-9.87-82.14
Long-Term Debt Repaid
-2,597-1,345-2,311-2,717
Total Debt Repaid
-3,729-1,472-2,321-2,799
Net Debt Issued (Repaid)
-1,225559.55492.71-1,358
Repurchase of Common Stock
---60.8-56.43
Common Dividends Paid
-1,042-563.22-553.97-610.49
Other Financing Activities
-186.05-1,193-114.58-458.73
Financing Cash Flow
-2,454-1,196-236.63-2,483
Foreign Exchange Rate Adjustments
0.16-1.2630.391.94
Net Cash Flow
-1,380-730.54807.36276.97
Free Cash Flow
1,4501,9071,8752,229
Free Cash Flow Growth
-23.98%1.68%-15.89%61.28%
Free Cash Flow Margin
17.06%21.98%21.71%28.04%
Free Cash Flow Per Share
0.971.281.281.48
Cash Interest Paid
8.41-4.05-
Cash Income Tax Paid
993.381,0991,1061,008
Levered Free Cash Flow
956.261,3481,5172,531
Unlevered Free Cash Flow
994.561,4001,5572,580
Change in Working Capital
215.24709.88535.211,281
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.